NASDAQ:SQNM - Sequenom Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.39
+0.30 (1.20%)
Get New Sequenom Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SQNM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SQNM

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Sequenom in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $2.39.

N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Sequenom. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/20/2016Jefferies Financial GroupReiterated RatingHold$1.50 ➝ $0.75N/A
i
6/29/2016William BlairReiterated RatingMarket PerformN/A
i
(Data available from 6/14/2016 forward)
Sequenom logo
Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.
Read More

Today's Range

Now: $2.39
$2.39
$2.39

50 Day Range

MA: N/A

52 Week Range

Now: $2.39
$0.82
$2.53

Volume

N/A

Average Volume

1,274,586 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Sequenom?

The following Wall Street research analysts have issued reports on Sequenom in the last twelve months:
View the latest analyst ratings for SQNM.

What is the current price target for Sequenom?

0 Wall Street analysts have set twelve-month price targets for Sequenom in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Sequenom in the next year.
View the latest price targets for SQNM.

What is the current consensus analyst rating for Sequenom?

Sequenom currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SQNM.

What other companies compete with Sequenom?

How do I contact Sequenom's investor relations team?

Sequenom's physical mailing address is 3595 John Hopkins Ct, SAN DIEGO, CA 92121-1121, United States. The biotechnology company's listed phone number is +1-858-2029000. The official website for Sequenom is www.sequenom.com.